IL6 and systemic inflammatory response syndrome: The present study consistently demonstrated that liver, lung, and kidney injuries were accompanied with IL‐6 increasing, and the mIL‐6R mAbs‐alleviated multiple organ dysfunctions, suggesting that prevention of IL‐6 signaling overactivation could reduce systemic inflammation and mitigate tissue injuries in SIRS.